Position
Chief Commercial Officer
Company
Oruka Therapeutics
Menlo ParkBiotechnologyHealthcareHealth CareTherapeuticsDescription
On August 24, 2026, Oruka Therapeutics, Inc. announced the hiring of Todd Edwards as Chief Commercial Officer. This decision was formalized through a letter agreement dated July 22, 2026, and his employment commenced on the same day.
Quick answer
Oruka Therapeutics Appoints Todd Edwards as Chief Commercial Officer (August 24, 2026). Oruka Therapeutics is based in Menlo Park, California, United States.
- Who is the new Chief Commercial Officer at Oruka Therapeutics?
- Oruka Therapeutics named Todd Edwards Chief Commercial Officer, announced August 24, 2026.
- What did Oruka Therapeutics announce on August 24, 2026?
- On August 24, 2026, Oruka Therapeutics, Inc. announced the hiring of Todd Edwards as Chief Commercial Officer. This decision was formalized through a letter agreement dated July 22, 2026, and his employment commenced on the same day.
- What does Oruka Therapeutics do?
- Oruka Therapeutics is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases.
- Where is Oruka Therapeutics based?
- Oruka Therapeutics is based in Menlo Park, California, United States.
- Which similar companies made leadership changes around the same time?
- Parabilis Medicines (August 25, 2026), Azora Therapeutics, Inc. (DE) (August 29, 2026), Beam Therapeutics Inc. (September 1, 2026) and Olema Oncology, Inc. (August 13, 2026) also announced leadership changes within 45 days of Oruka Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Healthcare and Therapeutics
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Parabilis Medicines Appoints Craig Tendler as Director (August 25, 2026)
- Adial Pharmaceuticals Appoints Matthew Davidson as President and CEO (August 29, 2026)
- Beam Therapeutics Appoints Eric Foster as Chief Commercial Officer (September 1, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Retension Pharmaceuticals Appoints LeAnne Bloedon as EVP of Clinical Development (September 10, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
Who to call at Oruka Therapeutics, and when
A new leader at Oruka Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Oruka Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Oruka Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Oruka Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Oruka Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Oruka Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.